Xiu-cheng Pan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xiu-cheng Pan

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of Zhejiang University. Science. B|September 15, 2006

Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomasXiu-cheng Pan, Zhi Chen, Feng Chen, et al.

Medicine|June 8, 2018

Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferonXia Wang, Zhi-Qiang Xu, Juan-Juan Fu, et al.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 25, 2004

[Establish a screening system for selection of mRNA target sites for HBsAg to construct siRNA with shRNA]Zheng-Gang Yang, Zhi Chen, Ning Xu, et al.

Oncology Letters|December 21, 2012

Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinomaXiu-Cheng Pan, Li Li, Juan-Juan Mao, et al.

Journal of Medical Virology|December 6, 2018

VDR rs7975232/ApaI genetic variation predicts sustained HBsAg loss in HBeAg-positive chronic hepatitis B patients treated with pegylated interferonBen Shan, Jun Yan Wang, Xia Wang, et al.

Acta Pharmacologica Sinica|June 13, 2025

Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcriptionHong-Juan You, Huan-Yang Zhang, Yu-Jie Zhong, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of Zhejiang University. Science. B|September 15, 2006

Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomasXiu-cheng Pan, Zhi Chen, Feng Chen, et al.

Medicine|June 8, 2018

Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferonXia Wang, Zhi-Qiang Xu, Juan-Juan Fu, et al.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 25, 2004

[Establish a screening system for selection of mRNA target sites for HBsAg to construct siRNA with shRNA]Zheng-Gang Yang, Zhi Chen, Ning Xu, et al.

Oncology Letters|December 21, 2012

Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinomaXiu-Cheng Pan, Li Li, Juan-Juan Mao, et al.

Journal of Medical Virology|December 6, 2018

VDR rs7975232/ApaI genetic variation predicts sustained HBsAg loss in HBeAg-positive chronic hepatitis B patients treated with pegylated interferonBen Shan, Jun Yan Wang, Xia Wang, et al.

Acta Pharmacologica Sinica|June 13, 2025

Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcriptionHong-Juan You, Huan-Yang Zhang, Yu-Jie Zhong, et al.

Pageof 2